Flechon, A; Morales-Barrera, R; Powles, T; Alva, A; Özgüroglu, M; Csöszi, T; Loriot, Y; Rodriguez-Vida, A; Géczi, L; Cheng, SY; Fradet, Y; Oudard, S; Vulsteke, C; Gunduz, S; Mamtani, R; Yu, EY; Pino, AM; Anido, U; Sendur, MAN; Gravis, G; Révész, J; Kostorov, V; Huillard, O; Ma, JS; Rajasagi, M; Vajdi, A; Lunceford, J; Cristescu, R; Imai, K; Moreno, BH; Matsubara, N – 2024 – 10.1158/1078-0432.CCR-23-3518
Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma – CLINICAL CANCER RESEARCH
by prodriguez | Jan 1, 2024 | Publicaciones - BE-23 | 0 comments